Column

Column|Stem Cell & Regenerative Medicine Insights

2026.07.20

Before Starting Stem Cell Conditioned Media Hair Regeneration for a Scalp Roughened by Scalp Pustular Folliculitis — Dr. Moriwaki Explains Why Chronic Pyoderma Must Be Calmed First and How Dermatologic Control Sets the Order of Treatment

2026.07.20

Don’t Mistake Nevus Sebaceous on the Scalp for Ordinary Hair Loss — Dr. Moriwaki Clarifies Where Stem Cell Conditioned Media Regenerative Medicine Reaches Its Limit

2026.07.20

Can We Use Cannulas on the Scalp? Dr. Moriwaki Compares Sharp Needles and Blunt Cannulas for Delivering Stem Cell Conditioned Media — Bleeding, Bruising, Uniformity

2026.07.19

How Many Growth Factors Are Really in One Lot of Stem Cell Conditioned Media? — Dr. Moriwaki Organizes the Pitfalls of the “More Is Better” Cocktail Mindset and the Quality Indicators That Truly Matter

2026.07.19

AGA in Men in Their 30s Is a Mid-Game That Separates “Density Already Lost” from “Density You Can Still Protect” — Dr. Moriwaki Organizes How to Fit Stem Cell Conditioned Media into AGA Treatment According to Progression

2026.07.19

Why the Pattern of Hair Loss Differs Between Hashimoto’s Disease and Graves’ Disease — Dr. Moriwaki Organizes the Difference Between Hypothyroidism and Hyperthyroidism in What Happens to the Hair, Together with the Positioning of Stem Cell Conditioned Media

2026.07.19

Scalp Lesions of Collagen Disease and Lupus Behind Hair Loss — Dr. Moriwaki Organizes the Signs of Discoid Lupus (DLE) Scarring Alopecia and When to Refer to Specialists

2026.07.18

Topical Finasteride and Topical Spironolactone as Options — Dr. Moriwaki Organizes How Topical Anti-Androgens and Stem Cell Conditioned Media Divide Roles

2026.07.18

M-Pattern AGA vs. Crown-Type AGA: How Stem Cell Conditioned Media Allocation Differs at Norwood III — Dr. Moriwaki Explains

1 … 11 12 13 14 15 … 32